Zhou et al. discovered that administering the targeted anti-cancer formula to activate blood circulation had a positive influence on the NK cell killing ability [100], besides stimulating IFN-γ emission from the T cells in the H22 liver cancer mice. This evidence concerns the gene IFNG and cancer.